Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS)
CNY 8.28
(-0.12%)
CNY 8.28
(-0.12%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1.16 Billion CNY | -26.17% |
| 2022 | 1.58 Billion CNY | 20.92% |
| 2021 | 1.3 Billion CNY | 40.69% |
| 2020 | 929.91 Million CNY | 14.63% |
| 2019 | 811.2 Million CNY | -3.27% |
| 2018 | 838.6 Million CNY | 0.25% |
| 2017 | 836.55 Million CNY | 30.52% |
| 2016 | 640.92 Million CNY | 30.02% |
| 2015 | 492.95 Million CNY | 76.19% |
| 2014 | 279.78 Million CNY | 52.13% |
| 2013 | 183.91 Million CNY | 193.28% |
| 2012 | 62.7 Million CNY | -82.77% |
| 2011 | 363.98 Million CNY | 104.07% |
| 2010 | 178.36 Million CNY | 141.97% |
| 2009 | 73.71 Million CNY | 57.43% |
| 2008 | 46.82 Million CNY | -39.53% |
| 2007 | 77.43 Million CNY | 541.98% |
| 2006 | 12.06 Million CNY | -25.53% |
| 2005 | 16.19 Million CNY | 120.7% |
| 2004 | -78.24 Million CNY | -316.55% |
| 2003 | 36.13 Million CNY | -9.72% |
| 2002 | 40.02 Million CNY | 36.44% |
| 2001 | 29.33 Million CNY | -36.66% |
| 2000 | 46.3 Million CNY | -31.5% |
| 1999 | 67.6 Million CNY | -27.0% |
| 1998 | 92.61 Million CNY | 2.18% |
| 1997 | 90.63 Million CNY | 11.16% |
| 1996 | 81.53 Million CNY | 19.76% |
| 1995 | 68.07 Million CNY | 40.65% |
| 1994 | 48.4 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 164.11 Million CNY | 136.87% |
| 2024 Q1 | 214.67 Million CNY | -47.34% |
| 2024 Q2 | -445.16 Million CNY | -307.37% |
| 2023 Q3 | 275.35 Million CNY | 17.49% |
| 2023 Q2 | 234.36 Million CNY | -6.42% |
| 2023 Q4 | 407.68 Million CNY | 48.06% |
| 2023 FY | 1.16 Billion CNY | -26.17% |
| 2023 Q1 | 250.43 Million CNY | 39.82% |
| 2022 Q1 | 831.2 Million CNY | 245.41% |
| 2022 Q3 | 220.2 Million CNY | -37.33% |
| 2022 Q4 | 179.11 Million CNY | -18.66% |
| 2022 Q2 | 351.35 Million CNY | -57.73% |
| 2022 FY | 1.58 Billion CNY | 20.92% |
| 2021 Q1 | 336.65 Million CNY | 93.23% |
| 2021 Q2 | 337.18 Million CNY | 0.16% |
| 2021 Q3 | 393.76 Million CNY | 16.78% |
| 2021 Q4 | 240.64 Million CNY | -38.89% |
| 2021 FY | 1.3 Billion CNY | 40.69% |
| 2020 Q4 | 174.22 Million CNY | -18.71% |
| 2020 Q2 | 263.89 Million CNY | -4.89% |
| 2020 Q1 | 277.46 Million CNY | 125.44% |
| 2020 FY | 929.91 Million CNY | 14.63% |
| 2020 Q3 | 214.33 Million CNY | -18.78% |
| 2019 Q4 | 123.08 Million CNY | -21.09% |
| 2019 FY | 811.2 Million CNY | -3.27% |
| 2019 Q3 | 155.98 Million CNY | -39.66% |
| 2019 Q1 | 273.62 Million CNY | 81.21% |
| 2019 Q2 | 258.51 Million CNY | -5.52% |
| 2018 Q3 | 150.9 Million CNY | -42.6% |
| 2018 FY | 838.6 Million CNY | 0.25% |
| 2018 Q4 | 150.99 Million CNY | 0.06% |
| 2018 Q1 | 273.8 Million CNY | 45.67% |
| 2018 Q2 | 262.9 Million CNY | -3.98% |
| 2017 Q4 | 187.96 Million CNY | -21.09% |
| 2017 Q2 | 200.09 Million CNY | -4.85% |
| 2017 FY | 836.55 Million CNY | 30.52% |
| 2017 Q1 | 210.29 Million CNY | 49.73% |
| 2017 Q3 | 238.19 Million CNY | 19.04% |
| 2016 Q3 | 185.29 Million CNY | 20.63% |
| 2016 Q1 | 161.56 Million CNY | 55.54% |
| 2016 FY | 640.92 Million CNY | 30.02% |
| 2016 Q4 | 140.45 Million CNY | -24.2% |
| 2016 Q2 | 153.61 Million CNY | -4.92% |
| 2015 FY | 492.95 Million CNY | 76.19% |
| 2015 Q4 | 103.86 Million CNY | -17.95% |
| 2015 Q3 | 126.58 Million CNY | -9.92% |
| 2015 Q2 | 140.53 Million CNY | 15.21% |
| 2015 Q1 | 121.97 Million CNY | 101.77% |
| 2014 Q4 | 60.45 Million CNY | -13.9% |
| 2014 FY | 279.78 Million CNY | 52.13% |
| 2014 Q1 | 80.34 Million CNY | 1928.47% |
| 2014 Q2 | 68.77 Million CNY | -14.4% |
| 2014 Q3 | 70.21 Million CNY | 2.09% |
| 2013 Q2 | 50.74 Million CNY | -23.7% |
| 2013 Q3 | 71.05 Million CNY | 40.01% |
| 2013 FY | 183.91 Million CNY | 193.28% |
| 2013 Q4 | -4.39 Million CNY | -106.18% |
| 2013 Q1 | 66.5 Million CNY | 195.78% |
| 2012 Q2 | 33.98 Million CNY | -21.69% |
| 2012 Q3 | 54.75 Million CNY | 61.11% |
| 2012 Q4 | -69.44 Million CNY | -226.81% |
| 2012 FY | 62.7 Million CNY | -82.77% |
| 2012 Q1 | 43.4 Million CNY | 196.8% |
| 2011 Q4 | -44.83 Million CNY | -112.71% |
| 2011 Q1 | 34.66 Million CNY | -34.91% |
| 2011 Q2 | 21.31 Million CNY | -38.5% |
| 2011 Q3 | 352.83 Million CNY | 1555.24% |
| 2011 FY | 363.98 Million CNY | 104.07% |
| 2010 Q4 | 53.25 Million CNY | 26.53% |
| 2010 Q2 | 45.07 Million CNY | 18.82% |
| 2010 FY | 178.36 Million CNY | 141.97% |
| 2010 Q1 | 37.94 Million CNY | 5451.53% |
| 2010 Q3 | 42.09 Million CNY | -6.63% |
| 2009 Q4 | -708.95 Thousand CNY | -101.56% |
| 2009 Q2 | 3.37 Million CNY | -86.82% |
| 2009 Q1 | 25.64 Million CNY | 353.53% |
| 2009 FY | 73.71 Million CNY | 57.43% |
| 2009 Q3 | 45.39 Million CNY | 1243.46% |
| 2008 FY | 46.82 Million CNY | -39.53% |
| 2008 Q4 | -10.11 Million CNY | -151.47% |
| 2008 Q3 | 19.65 Million CNY | -2.08% |
| 2008 Q1 | 17.21 Million CNY | -18.15% |
| 2008 Q2 | 20.07 Million CNY | 16.61% |
| 2007 Q2 | 34.32 Million CNY | 164.73% |
| 2007 Q3 | 9.1 Million CNY | -73.47% |
| 2007 FY | 77.43 Million CNY | 541.98% |
| 2007 Q4 | 21.03 Million CNY | 130.92% |
| 2007 Q1 | 12.96 Million CNY | 137.43% |
| 2006 Q4 | -34.64 Million CNY | -310.53% |
| 2006 Q1 | 6.31 Million CNY | 397.72% |
| 2006 Q3 | 16.45 Million CNY | -31.24% |
| 2006 FY | 12.06 Million CNY | -25.53% |
| 2006 Q2 | 23.93 Million CNY | 278.76% |
| 2005 Q2 | 10.94 Million CNY | 113.16% |
| 2005 Q1 | 5.13 Million CNY | 105.41% |
| 2005 Q3 | 2.23 Million CNY | -79.59% |
| 2005 Q4 | -2.12 Million CNY | -195.0% |
| 2005 FY | 16.19 Million CNY | 120.7% |
| 2004 Q2 | 6.73 Million CNY | -22.81% |
| 2004 FY | -78.24 Million CNY | -316.55% |
| 2004 Q4 | -94.84 Million CNY | -8476.5% |
| 2004 Q3 | 1.13 Million CNY | -83.2% |
| 2004 Q1 | 8.73 Million CNY | 93.89% |
| 2003 Q2 | 14.27 Million CNY | 65.97% |
| 2003 Q3 | 8.76 Million CNY | -38.6% |
| 2003 Q4 | 4.5 Million CNY | -48.61% |
| 2003 FY | 36.13 Million CNY | -9.72% |
| 2003 Q1 | 8.59 Million CNY | -14.8% |
| 2002 Q4 | 10.09 Million CNY | -15.0% |
| 2002 Q3 | 11.87 Million CNY | -16.2% |
| 2002 Q1 | 3.88 Million CNY | 0.0% |
| 2002 FY | 40.02 Million CNY | 36.44% |
| 2002 Q2 | 14.16 Million CNY | 264.44% |
| 2001 FY | 29.33 Million CNY | -36.66% |
| 2000 FY | 46.3 Million CNY | -31.5% |
| 1999 FY | 67.6 Million CNY | -27.0% |
| 1998 FY | 92.61 Million CNY | 2.18% |
| 1997 FY | 90.63 Million CNY | 11.16% |
| 1996 FY | 81.53 Million CNY | 19.76% |
| 1995 FY | 68.07 Million CNY | 40.65% |
| 1994 FY | 48.4 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 4.3 Billion CNY | 72.856% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 2.79 Billion CNY | 58.252% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 591.57 Million CNY | -97.412% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 57 Million CNY | -1948.81% |
| Aurora Optoelectronics Co.,Ltd. | -675.27 Million CNY | 272.941% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | -38.27 Million CNY | 3151.158% |
| NanJing Pharmaceutical Company Limited | 577.82 Million CNY | -102.109% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 90.07 Million CNY | -1196.463% |